← Eichor
Study identifier: NCT07422935 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Plant-Protein Dominant Tube Feed Study

Condition: Enteral Nutrition (Food for Special Medical Purposes) · Enteral Feeds  ·  Sponsor: Nutricia UK Ltd

PhaseNA
Planned participants110
Who can joinAll sexes, 16 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to determine whether a reformulated plant-protein dominant protein blend in four existing enteral tube feeds is as effective as animal-protein dominant formulations in patients who are tube fed at home. This is an exploratory randomised, controlled, trial with a 3-day baseline period. Adult home tube feeding patients will be randomised to receive either a plant-protein dominant formulation or a control product (an animal-protein dominant formulation) for a 3-month intervention period followed by a 6-month and 12-month follow-up. The outcomes include gastrointestinal tolerance, compliance, acceptability, anthropometry, nutrient intake, and physical function

This description comes directly from the study's public registry record.

Talk to the study team

Sophie Bell  ·  +7717498628  ·  sophie.bell@nutricia.com

Ellen Taylor  ·  ellen.taylor@nutricia.com

Always discuss trial participation with your own doctor first.

Locations (1)

Nutricia LtdTrowbridge, Wiltshire, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07422935